GlassScriptPhysician profile
Krikor Manoukian
NPI 1740519586
$13,442.33
in general payments reported to CMS, 2019-2025
34 companies · $1,561 in 2025
The $1,561 reported for 2025 was more than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,381 · 2020: $985 · 2021: $1,699 · 2022: $1,391 · 2023: $1,489 · 2024: $1,937 · 2025: $1,561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,986.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,986.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $3,747.75 | 2019-2025 | |
| Glaxosmithkline, LLC. | $1,944.89 | 2019-2025 | Nucala, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $1,201.45 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Genzyme Corporation | $907.18 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $790.53 | 2019-2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $681.93 | 2020-2025 | Cuvitru, Takhzyro |
| Pfizer INC. | $635.97 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $600.64 | 2019-2025 | |
| Csl Behring | $400.05 | 2019-2025 | Hizentra, Haegarda, Andembry |
| Genentech USA, INC. | $337.42 | 2019-2025 | Xolair |
| Genentech, INC. | $333.42 | 2023-2024 | Xolair |
| Boehringer Ingelheim Pharmaceuticals, INC. | $289.56 | 2019-2023 | Spiriva Respimat, Stiolto Respimat |
| Grifols USA, LLC | $242.43 | 2019-2025 | Xembify |
| Incyte Corporation | $186.72 | 2022-2025 | Opzelura |
| Pharming Healthcare, INC. | $162.43 | 2019-2024 | Ruconest |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $120.47 | 2019-2024 | Auvi-Q |
| Phadia US INC. | $101.13 | 2021-2024 | Immunocap |
| Biocryst US Sales Co., LLC | $89.33 | 2021-2023 | Orladeyo |
| Teva Pharmaceuticals USA, INC. | $85.74 | 2019-2020 | |
| Amgen INC. | $81.20 | 2022 | |
| Leo Pharma INC. | $77.70 | 2022-2025 | Adbry |
| Shire North American Group INC | $64.69 | 2019 | |
| Horizon Therapeutics Plc | $58.06 | 2019-2021 | |
| Ionis Pharmaceuticals, INC. | $53.80 | 2025 | Dawnzera |
| Sanofi-Aventis U.S. LLC | $48.90 | 2019 | |
| Aimmune Therapeutics, INC. | $29.86 | 2022 | |
| Blueprint Medicines Corporation | $27.82 | 2023 | Ayvakit |
| Merck Sharp & Dohme LLC | $24.05 | 2021 | |
| Eyevance Pharmaceuticals LLC | $23.00 | 2020 | |
| Hikma Pharmaceuticals USA | $22.22 | 2024 | Ryaltris |
| Sunovion Pharmaceuticals INC. | $21.42 | 2019 | |
| Cycle Pharmaceuticals INC | $17.68 | 2025 | Sajazir |
| Galderma Laboratories, L.P. | $17.36 | 2025 | Nemluvio |
| Medline Industries LP | $15.53 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krikor Manoukian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.